LON:RTW RTW Biotech Opportunities (RTW) Share Price, News & Analysis GBX 1.40 0.00 (-0.21%) As of 08/22/2025 12:05 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlinesBuy This Stock About RTW Biotech Opportunities Stock (LON:RTW) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get RTW alerts:Sign Up Key Stats Today's Range 1.39▼ 1.4150-Day Range 1.15▼ 1.4152-Week Range 1.08▼ 1.58Volume109,205 shsAverage Volume302,196 shsMarket Capitalization£470.28 millionP/E Ratio3.34Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Bio invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives. RTW Bio is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies. Read More Receive RTW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RTW Biotech Opportunities and its competitors with MarketBeat's FREE daily newsletter. Email Address RTW Stock News HeadlinesThe healthcare sector is unloved – this trust is a prime exampleJuly 17, 2025 | finance.yahoo.comRTWFF RTW Biotech Opportunities Ltd - Seeking AlphaJuly 1, 2025 | seekingalpha.comWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was projected. According to Porter Stansberry, this is panic-level borrowing… and a clear sign we’re nearing America’s financial breaking point. In his latest emergency briefing, Porter outlines why the cracks in our system are widening fast—and how Trump’s policies may be accelerating the collapse. More importantly, he reveals three moves you can make now to protect and potentially grow your wealth before the levee breaks.August 24 at 2:00 AM | Porter & Company (Ad)RTW Biotech hails Corxel obesity drug progress in US, China trialsJune 24, 2025 | lse.co.ukThis trust buys shares that can double in a day or be wiped out. The risk could be worth itJune 19, 2025 | finance.yahoo.comRTW Biotech investee sees encouraging results in cardiac disease trialMay 20, 2025 | lse.co.ukRTW Biotech Opportunities Ltd schedules June AGMMay 16, 2025 | investing.comRTW Biotech Opportunities notes positive trial data from investeeMay 2, 2025 | lse.co.ukSee More Headlines RTW Stock Analysis - Frequently Asked Questions How have RTW shares performed this year? RTW Biotech Opportunities' stock was trading at GBX 1.39 at the beginning of the year. Since then, RTW shares have increased by 0.7% and is now trading at GBX 1.40. How do I buy shares of RTW Biotech Opportunities? Shares of RTW stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Industry, Sector and Symbol Stock ExchangeLON SectorFinancial Services Industry Asset Management Sub-IndustryN/A Current SymbolLON:RTW CIKN/A Webwww.rtwfunds.com Phone646-597-6980FaxN/AEmployees4,971Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX 0.42 Trailing P/E Ratio3.34 Forward P/E RatioN/A P/E GrowthN/ANet Income£14.09 billion Net Margins664.38% Pretax MarginN/A Return on Equity25.18% Return on Assets-0.47% Debt Debt-to-Equity Ratio2.27 Current RatioN/A Quick Ratio0.81 Sales & Book Value Annual Sales£2.12 billion Price / Sales0.22 Cash FlowGBX 4.35 per share Price / Cash Flow0.32 Book ValueGBX 210.25 per share Price / Book0.01Miscellaneous Outstanding Shares33,591,400,000Free FloatN/AMarket Cap£470.28 million OptionableNot Optionable Beta0.60 The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (LON:RTW) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RTW Biotech Opportunities Please log in to your account or sign up in order to add this asset to your watchlist. Share RTW Biotech Opportunities With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access